These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31864680)

  • 41. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
    Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
    Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural Prediction of the Dimeric Form of the Mammalian Translocator Membrane Protein TSPO: A Key Target for Brain Diagnostics.
    Zeng J; Guareschi R; Damre M; Cao R; Kless A; Neumaier B; Bauer A; Giorgetti A; Carloni P; Rossetti G
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.
    Yasin N; Veenman L; Singh S; Azrad M; Bode J; Vainshtein A; Caballero B; Marek I; Gavish M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Translocator protein: pharmacology and steroidogenesis.
    Midzak A; Zirkin B; Papadopoulos V
    Biochem Soc Trans; 2015 Aug; 43(4):572-8. PubMed ID: 26551695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The translocator protein (TSPO): a novel target for cancer chemotherapy.
    Austin CJ; Kahlert J; Kassiou M; Rendina LM
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1212-6. PubMed ID: 23518318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Translocator protein (TSPO) and neurosteroids: implications in psychiatric disorders.
    Da Pozzo E; Costa B; Martini C
    Curr Mol Med; 2012 May; 12(4):426-42. PubMed ID: 22348611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site.
    Rojas C; Stathis M; Coughlin JM; Pomper M; Slusher BS
    J Neuroimmune Pharmacol; 2018 Mar; 13(1):1-5. PubMed ID: 28875261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mutual and dynamic role of TSPO and ligands in their binding process: An example with PK-11195.
    Rao RM; El Dhaybi I; Cadet F; Etchebest C; Diharce J
    Biochimie; 2024 Mar; ():. PubMed ID: 38494108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons.
    Barron AM; Higuchi M; Hattori S; Kito S; Suhara T; Ji B
    Mol Neurobiol; 2021 Feb; 58(2):550-563. PubMed ID: 32989676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.
    Fairley LH; Sahara N; Aoki I; Ji B; Suhara T; Higuchi M; Barron AM
    J Neuroinflammation; 2021 Mar; 18(1):76. PubMed ID: 33740987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of TSPO PET Ligands [
    Tang D; Li J; Buck JR; Tantawy MN; Xia Y; Harp JM; Nickels ML; Meiler J; Manning HC
    Mol Imaging Biol; 2017 Aug; 19(4):578-588. PubMed ID: 27853987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.
    Lee YS; Siméon FG; Briard E; Pike VW
    ACS Chem Neurosci; 2012 Apr; 3(4):325-35. PubMed ID: 22860199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The translocator protein.
    Scarf AM; Kassiou M
    J Nucl Med; 2011 May; 52(5):677-80. PubMed ID: 21498529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant.
    Asih PR; Poljak A; Kassiou M; Ke YD; Ittner LM
    PLoS One; 2022; 17(5):e0254296. PubMed ID: 35522669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and in vitro evaluation of new translocator protein ligands designed for positron emission tomography.
    Kalina T; Berroterán-Infante N; Schmitl S; Vraka C; Hacker M; Mitterhauser M; Pallitsch K; Wadsak W
    Future Med Chem; 2019 Mar; 11(6):539-550. PubMed ID: 30888874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent progress on the development of fluorescent probes targeting the translocator protein 18 kDa (TSPO).
    Wongso H
    Anal Biochem; 2022 Oct; 655():114854. PubMed ID: 35963341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TSPO: An Evolutionarily Conserved Protein with Elusive Functions.
    Bonsack F; Sukumari-Ramesh S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29875327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.